Alchemix: A novel alkylating anthraquinone with potent activity against anthracycline- and cisplatin-resistant ovarian cancer

Pors, K., Paniwnyk, Z., Teesdale-Spittle, P., Plumb, J., Willmore, E., Austin, C. and Patterson, L. (2003) Alchemix: A novel alkylating anthraquinone with potent activity against anthracycline- and cisplatin-resistant ovarian cancer. Molecular Cancer Therapeutics, 2, pp. 607-610.

Full text not currently available from Enlighten.


Item Type:Articles
Status:Published
Refereed:Yes
Glasgow Author(s) Enlighten ID:Plumb, Dr Jane
Authors: Pors, K., Paniwnyk, Z., Teesdale-Spittle, P., Plumb, J., Willmore, E., Austin, C., and Patterson, L.
College/School:College of Medical Veterinary and Life Sciences
Journal Name:Molecular Cancer Therapeutics

University Staff: Request a correction | Enlighten Editors: Update this record